Jaglin J - Search Results

1

The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease.

Videnovic A, Bernard B, Fan W, Jaglin J, Leurgans S, Shannon KM. Videnovic A, et al. Among authors: jaglin j. Mov Disord. 2010 Feb 15;25(3):401-4. doi: 10.1002/mds.22748. Mov Disord. 2010. PMID: 20108371

2

Daytime somnolence and nocturnal sleep disturbances in Huntington disease.

Videnovic A, Leurgans S, Fan W, Jaglin J, Shannon KM. Videnovic A, et al. Among authors: jaglin j. Parkinsonism Relat Disord. 2009 Jul;15(6):471-4. doi: 10.1016/j.parkreldis.2008.10.002. Epub 2008 Nov 28. Parkinsonism Relat Disord. 2009. PMID: 19041273

3

Effect of donepezil on motor and cognitive function in Huntington disease.

Cubo E, Shannon KM, Tracy D, Jaglin JA, Bernard BA, Wuu J, Leurgans SE. Cubo E, et al. Among authors: jaglin ja. Neurology. 2006 Oct 10;67(7):1268-71. doi: 10.1212/01.wnl.0000238106.10423.00. Neurology. 2006. PMID: 17030764 Clinical Trial.

4

Suicidal ideation in Huntington disease: the role of comorbidity.

Wetzel HH, Gehl CR, Dellefave-Castillo L, Schiffman JF, Shannon KM, Paulsen JS; Huntington Study Group. Wetzel HH, et al. Psychiatry Res. 2011 Aug 15;188(3):372-6. doi: 10.1016/j.psychres.2011.05.006. Epub 2011 May 24. Psychiatry Res. 2011. PMID: 21605914 Free PMC article.

5

Extensor truncal dystonia: successful treatment with botulinum toxin injections.

Comella CL, Shannon KM, Jaglin J. Comella CL, et al. Among authors: jaglin j. Mov Disord. 1998 May;13(3):552-5. doi: 10.1002/mds.870130330. Mov Disord. 1998. PMID: 9613753 Clinical Trial.

6

A randomized, placebo-controlled trial of latrepirdine in Huntington disease.

Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, Seely L, Walker F, Feigin A; Huntington Disease Study Group DIMOND Investigators. Kieburtz K, et al. Arch Neurol. 2010 Feb;67(2):154-60. doi: 10.1001/archneurol.2009.334. Arch Neurol. 2010. PMID: 20142523 Free PMC article. Clinical Trial.

7

Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease.

Elble RJ, Suchowersky O, Shaftman S, Weiner WJ, Huang P, Tilley B; NINDS NET-PD Investigators. Elble RJ, et al. Mov Disord. 2010 Jun 15;25(8):1082-6. doi: 10.1002/mds.22997. Mov Disord. 2010. PMID: 20131372 Free PMC article.

8

Earliest functional declines in Huntington disease.

Beglinger LJ, O'Rourke JJ, Wang C, Langbehn DR, Duff K, Paulsen JS; Huntington Study Group Investigators. Beglinger LJ, et al. Psychiatry Res. 2010 Jul 30;178(2):414-8. doi: 10.1016/j.psychres.2010.04.030. Epub 2010 May 15. Psychiatry Res. 2010. PMID: 20471695 Free PMC article.

9

Comorbidities of obsessive and compulsive symptoms in Huntington's disease.

Anderson KE, Gehl CR, Marder KS, Beglinger LJ, Paulsen JS; Huntington's Study Group. Anderson KE, et al. J Nerv Ment Dis. 2010 May;198(5):334-8. doi: 10.1097/NMD.0b013e3181da852a. J Nerv Ment Dis. 2010. PMID: 20458194 Free PMC article.

10

Characterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study.

Huntington Study Group COHORT Investigators; Dorsey E. Huntington Study Group COHORT Investigators, et al. PLoS One. 2012;7(2):e29522. doi: 10.1371/journal.pone.0029522. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359536 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters